Treatment

VESSEL® 250 ULS capsule molli clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic confirmatory (Phase III)
The Jason Study: Sulodexide (VESSEL®) for the prevention of recurrent venous thromboembolism in elderly patients after a first episode of venous thrombembolism
The Jason Study is looking at a medicine called Sulodexide (Vessel®) to see if it can stop blood clots (VTE) from coming back in older patients after their first clot. It also checks for serious side effects like bleeding.
For: Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)
Italy